RA Capital's 9% stake signals conviction but is filed as passive (13G). Monitor for any future conversion to 13D or additional purchases, which would indicate a shift toward activist intent. The stake was acquired via a public offering, so near-term selling pressure from the offering is likely absorbed.
Price Chart
Executive Summary
RA Capital Management, L.P. and affiliated entities disclosed a 9.0% passive stake in BetterLife Pharma Inc., holding 55,420,000 common shares as of September 15, 2026. The filing is a Schedule 13G, indicating no intent to influence control, and the stake was acquired in connection with a public offering that closed on the same date.
Key Financial Metrics
Key Facts
- RA Capital Management, L.P. and affiliated entities beneficially own 55,420,000 common shares of BetterLife Pharma Inc.
- The stake represents 9.0% of shares outstanding, based on 170,965,339 shares outstanding as of September 10, 2026 plus 447,041,840 shares issued in a public offering that closed September 15, 2026.
- The filing is a Schedule 13G, certifying the securities were not acquired with the purpose of changing or influencing control.
- The Fund directly holds the shares; RA Capital Management serves as investment adviser with sole voting and dispositive power.
Financial Impact
9.0% passive stake valued at an undisclosed amount; acquired in connection with a public offering that closed September 15, 2026.
Risk Factors
- RA Capital could convert to a 13D and pursue activist strategies, though no such intent is indicated.
- The stake was acquired in a public offering, which may have diluted existing shareholders.
- BetterLife Pharma is a clinical-stage biotech with no approved products, carrying inherent development and regulatory risk.
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| SC 13G Filing (Primary) | 0001346824-26-000241 |
| Document: 0001346824-26-000241-index-headers.html | 0001346824-26-000241 |
| Document: 0001346824-26-000241-index.html | 0001346824-26-000241 |
| Document: 0001346824-26-000241.txt | 0001346824-26-000241 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 29, 2026 26d ago | 6-K | $0.2410 $0.1920 | ▼ −20.33% | ▼ −22.25% | $0.1685 (−30.08%) |
Sep 22, 2026 4w ago | SC 13G | $0.2400 $0.2410 | ▲ +0.42% | ▲ +1.09% | $0.1685 (−29.79%) |
Sep 15, 2026 5w ago | 6-K | $0.2740 $0.2217 | ▼ −19.09% | ▼ −19.91% | $0.1685 (−38.50%) |
Sep 11, 2026 6w ago | 6-K | $0.2300 $0.2550 | ▲ +10.87% | ▲ +11.09% | $0.1685 (−26.74%) |
Aug 24, 2026 9w ago | 6-K | $0.2240 $0.2195 | ▼ −2.01% | ▼ −2.48% | $0.1685 (−24.78%) |
Jun 26, 2026 17w ago | 6-K | $0.1110 $0.1310 | ▲ +18.02% | ▲ +15.85% | $0.1685 (+51.80%) |
Apr 13, 2026 28w ago | 6-K | $0.0410 $0.0480 | ▲ +17.07% | ▲ +13.78% | $0.1685 (+310.98%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers